Vantage Oncology Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vantage Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013289
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gynecological, prostate, skin, and lung cancer. Vantage Oncology’s medical oncology includes initial consultation, diagnosis, pre-treatment planning, treatment and post-treatment care and on-going support. The company also provides strategic planning, accounting resources, information systems consulting, managed care contracting, human resources and marketing services. It partners with clients in the field of radiation oncology. The company serves to patients, physicians, and hospitals. Vantage Oncology is headquartered in Manhattan Beach, California, the US.

Vantage Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vantage Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vantage Oncology Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Vantage Oncology Enters Into Joint Venture With Valley Radiotherapy To Form Holy Cross Radiation Therapy Center 11
Vantage Oncology Forms Joint Venture With Valley Radiotherapy Associates Medical 12
Vantage Oncology And TriHealth Form Joint Venture To Offer Radiation Oncology Services 13
Merger 14
Physician Oncology Services Completes Merger With Vantage Oncology 14
Acquisition 16
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 16
Vantage Oncology Acquires Radiation Oncology Services of America From U.S. Renal Care 18
Vantage Oncology Inc – Key Competitors 19
Vantage Oncology Inc – Key Employees 20
Vantage Oncology Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 23
Government and Public Interest 23
Aug 25, 2016: New Study Shows Lumpectomy With Radiation Therapy to Treat Breast Cancer in a Community Setting Results in Higher Than Average Patient Survival Rates 23
Aug 25, 2016: Vantage Oncology And Valley Radiotherapy Associates Medical Group Study Shows Lumpectomy With Radiation Therapy To Treat Breast Cancer In A Community Setting Results In Higher Than Average Patient Survival Rates 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vantage Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vantage Oncology Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vantage Oncology Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vantage Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vantage Oncology Enters Into Joint Venture With Valley Radiotherapy To Form Holy Cross Radiation Therapy Center 11
Vantage Oncology Forms Joint Venture With Valley Radiotherapy Associates Medical 12
Vantage Oncology And TriHealth Form Joint Venture To Offer Radiation Oncology Services 13
Physician Oncology Services Completes Merger With Vantage Oncology 14
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 16
Vantage Oncology Acquires Radiation Oncology Services of America From U.S. Renal Care 18
Vantage Oncology Inc, Key Competitors 19
Vantage Oncology Inc, Key Employees 20
Vantage Oncology Inc, Subsidiaries 21
Vantage Oncology Inc, Joint Venture 21

★海外企業調査レポート[Vantage Oncology Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nanosphere Inc-医療機器分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Claire’s Stores Inc:企業の戦略・SWOT・財務分析
    Claire's Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Claire's Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cohu, Inc. (COHU):企業の財務・戦略的SWOT分析
    Cohu, Inc. (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Recondo Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary Recondo Technology Inc (Recondo) is a provider of cloud-based software and services that streamline operations in the healthcare industry. The company provides Empowered Patient Access, Empowered Business Office, and Empowered Technology solutions to connect providers with payers and their p …
  • W. L. Gore & Associates Inc-医療機器分野:企業M&A・提携分析
    Summary W. L. Gore & Associates Inc (Gore) is a manufacturer and distributor of fluoropolymer products. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company has developed numerous products for medica …
  • Trusted Media Brands, Inc.:企業の戦略的SWOT分析
    Trusted Media Brands, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • S&T Dynamics Co., Ltd.:企業の戦略・SWOT・財務情報
    S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Engie S.A.:企業のM&A・事業提携・投資動向
    Engie S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Engie S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • VION N.V.:企業の戦略・SWOT・財務情報
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Australian Vintage Limited:企業の戦略・SWOT・財務情報
    Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Didion Milling Inc.:企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Centene Corp (CNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DrillingInfo Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary DrillingInfo Inc (DrillingInfo) is an oil and gas service provider that offers upstream drilling services and oilfield services. The company's products include DI courthouse, DI analytics, DI basic, DI engineering, DI international product line, DI geodata services, DI rig analytics, DI play …
  • X-ELIO Energy SL:電力:M&Aディール及び事業提携情報
    Summary X-ELIO Energy SL (X-ELIO), formerly Gestamp Solar, a subsidiary of Corporacion Gestamp S.L. is an alternative energy company that operates utility scale photovoltaic power plants. The company constructs, designs, installs, develops, and maintains solar photovoltaic plants. Its development, c …
  • AiCuris GmbH & Co KG-製薬・医療分野:企業M&A・提携分析
    Summary AiCuris GmbH & Co KG (AiCuris), a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Aerpio Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aerpio Therapeutics Inc (Aerpio) is a biopharmaceutical company that develops novel monoclonal antibodies and small molecules. The company’s programs include a Tie-2 activator for diabetic macular edema and a hypoxia-inducible factor stabilizer for the treatment of inflammatory bowel disease …
  • Tiziana Life Sciences Plc (TILS):医療機器:M&Aディール及び事業提携情報
    Summary Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company’s lead product candidate, TZLS-201, intended for the treatment of thymic carcin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆